SEC Filing | Stereotaxis Inc.

View:

SEC FORM 4 SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Lele Abhijeet J

(Last)

(First)

(Middle)

C/O EGS HEALTHCARE

105 ROWAYTON AVE., 2ND FLOOR

(Street)

ROWAYTON

06853

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Stereotaxis, Inc. [ STXS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/17/2004

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	08/17/2004		C		42,072⁽¹⁾	A	⁽²⁾	42,072	I	EGS Private Healthcare Counterpart, L.P.
Common Stock	08/17/2004		C		16,146⁽¹⁾	A	⁽²⁾	58,218	I	EGS Private Healthcare Counterpart, L.P.
Common Stock	08/17/2004		C		25,201⁽¹⁾	A	⁽²⁾	83,419	I	EGS Private Healthcare Counterpart, L.P.
Common Stock	08/17/2004		C		294,508⁽¹⁾	A	⁽²⁾	294,508	I	EGS Private Healthcare Partnership, L.P.
Common Stock	08/17/2004		C		113,022⁽¹⁾	A	⁽²⁾	407,530	I	EGS Private Healthcare Partnership, L.P.
Common Stock	08/17/2004		C		176,411⁽¹⁾	A	⁽²⁾	583,941	I	EGS Private Healthcare Partnership, L.P.
Common Stock	08/17/2004		C		76,624⁽¹⁾	A	⁽²⁾	76,624	I	EGS Private Healthcare Canadian Partners, L.P.
Common Stock	08/17/2004		C		61,300⁽¹⁾	A	⁽²⁾	137,924	I	EGS Private Healthcare Canadian Partners L.P.
Common Stock	08/17/2004		C		509,215⁽¹⁾	A	⁽²⁾	509,215	I	EGS Private Healthcare Partnership II, L.P.
Common Stock	08/17/2004		C		407,371⁽¹⁾	A	⁽²⁾	916,586	I	EGS Private Healthcare Partnership II, L.P.
Common Stock	08/17/2004		C		80,308⁽¹⁾	A	⁽²⁾	80,308	I	EGS Private Healthcare Investors II, L.P.
Common Stock	08/17/2004		C		64,246⁽¹⁾	A	⁽²⁾	144,554	I	EGS Private Healthcare Investors II, L.P.
Common Stock	08/17/2004		C		5,894⁽¹⁾	A	⁽²⁾	5,894	I	EGS Private Healthcare President's Fund, L.P.
Common Stock	08/17/2004		C		4,715⁽¹⁾	A	⁽²⁾	10,609	I	EGS Private Healthcare President's Fund, L.P.

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Series D Convertible Preferred Stock	⁽²⁾	08/17/2004		C			150,101	⁽³⁾	⁽³⁾	Common Stock	41,694	⁽²⁾	0	I	EGS Private Healthcare Counterpart, L.P.
Series D Convertible Preferred Stock	⁽²⁾	08/17/2004		C			1,050,708	⁽³⁾	⁽³⁾	Common Stock	291,863	⁽²⁾	0	I	EGS Private Healthcare Partnership, L.P.
Series D-1 Convertible Preferred Stock	⁽²⁾	08/17/2004		C			57,604	⁽³⁾	⁽³⁾	Common Stock	16,001	⁽²⁾	0	I	EGS Private Healthcare Counterpart, L.P.
Series D-1 Convertible Preferred Stock	⁽²⁾	08/17/2004		C			403,226	⁽³⁾	⁽³⁾	Common Stock	112,007	⁽²⁾	0	I	EGS Private Healthcare Partnership, L.P.
Series D-2 Convertible Preferred Stock	⁽²⁾	08/17/2004		C			262,714	⁽³⁾	⁽³⁾	Common Stock	72,976	⁽²⁾	0	I	EGS Private Healthcare Canadian Partners, L.P.
Series D-2 Convertible Preferred Stock	⁽²⁾	08/17/2004		C			86,406	⁽³⁾	⁽³⁾	Common Stock	24,001	⁽²⁾	0	I	EGS Private Healthcare Counterpart, L.P.
Series D-2 Convertible Preferred Stock	⁽²⁾	08/17/2004		C			275,343	⁽³⁾	⁽³⁾	Common Stock	76,484	⁽²⁾	0	I	EGS Private Healthcare Investors, L.P.
Series D-2 Convertible Preferred Stock	⁽²⁾	08/17/2004		C			1,745,882	⁽³⁾	⁽³⁾	Common Stock	484,967	⁽²⁾	0	I	EGS Private Healthcare Partnership II, L.P.
Series D-2 Convertible Preferred Stock	⁽²⁾	08/17/2004		C			604,839	⁽³⁾	⁽³⁾	Common Stock	168,010	⁽²⁾	0	I	EGS Private Healthcare Partnership, L.P.
Series D-2 Convertible Preferred Stock	⁽²⁾	08/17/2004		C			20,209	⁽³⁾	⁽³⁾	Common Stock	5,613	⁽²⁾	0	I	EGS Private Healthcare President's Fund, L.P.
Series E-2 Convertible Preferred Stock	⁽²⁾	08/17/2004		C			155,656	⁽³⁾	⁽³⁾	Common Stock	43,237	⁽²⁾	0	I	EGS Private Healthcare Canadian Partners, L.P.
Series E-2 Convertible Preferred Stock	⁽²⁾	08/17/2004		C			163,139	⁽³⁾	⁽³⁾	Common Stock	45,316	⁽²⁾	0	I	EGS Private Healthcare Investors II, L.P.
Series E-2 Convertible Preferred Stock	⁽²⁾	08/17/2004		C			1,034,419	⁽³⁾	⁽³⁾	Common Stock	287,338	⁽²⁾	0	I	EGS Private Healthcare Partnership II, L.P.
Series E-2 Preferred Stock	⁽²⁾	08/17/2004		C			11,974	⁽³⁾	⁽³⁾	Common Stock	3,326	⁽²⁾	0	I	EGS Private Healthcare President's Fund, L.P.

Explanation of Responses:

1. The number of shares of common stock received upon conversion of the reporting person's convertible preferred stock includes additional shares issued as a result of antidilution provisions triggered by the issuer's initial public offering.

2. Price is not applicable to conversion of preferred stock to common stock.

3. All series of the Issuer's Convertible Preferred Stock are convertible into common stock upon demand at any time.

	/s/ Abhijeet J. Lele	08/18/2004
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Innovation Day